Many households maintain a stockpile of leftover medications, ranging from basic fever reducers and cold remedies to leftover antibiotics and allergy treatments. While some are over-the-counter products easily purchased at a local pharmacy, others are high-potency prescription drugs. Although patients typically consult a doctor or pharmacist when a medication is first dispensed, they frequently turn to self-medication based on personal experience once those drugs are sitting at home. Global health authorities consistently warn against this practice, as misusing or overusing leftover medications can cause severe systemic harm.
With the arrival of summer, many individuals find themselves grappling with a sudden onset of a runny nose, nasal congestion, sneezing, and localized itching. These symptoms are often driven by allergic rhinitis—an inflammatory condition of the nasal passages triggered by environmental allergens such as house dust mites, pet dander, pollen, or mold. Because the specific antigens triggering these reactions vary wildly from person to person, treatment protocols must be carefully individualized. Reaching for a leftover rhinitis medication without professional guidance can inadvertently trigger adverse vascular side effects.
The Hidden Vascular Costs of Topical and Systemic Steroids
Allergic rhinitis is typically managed through oral medications or localized nasal sprays designed to deliver steroids or antihistamines directly to the nasal mucosa. However, the long-term, unmonitored use of topical nasal steroids can cause localized capillaries to dilate permanently, weakening blood vessel architecture.
Even more critically, data from the Korea Disease Control and Prevention Agency (KDCA) indicates that the prolonged, unapproved use of systemic oral steroids can severely interfere with physical growth and development in younger patients. To safely manage these conditions, individuals must undergo proper clinical evaluations—such as diagnostic skin prick tests or specialized blood assays—to pinpoint the exact underlying antigen, and use these targeted medications strictly under a physician's oversight.
The Post-Antibiotic Era: Why the Common Cold Resists '-Mycin'
Historically, antibiotics ending in "-mycin" were widely viewed by the public as catch-all remedies for illness, leading many individuals to indiscriminately consume them at the first sign of a common cold. This precise pattern of misuse directly fuels antibiotic resistance—a dangerous evolutionary process where surviving bacteria mutate to render standard therapeutic drugs entirely ineffective.
When resistance takes hold, treating common bacterial infections becomes extraordinarily difficult, drastically reducing the pool of available, effective therapeutics. This trend poses a catastrophic threat to vulnerable populations, particularly immunocompromised individuals and patients battling severe, acute systemic infections. Recognizing the gravity of this crisis, the World Health Organization (WHO) has officially designated antimicrobial resistance as one of the top ten public health threats facing humanity.
Shared Accountability: Redefining Antibiotic Stewardship
It is a fundamental clinical reality that antibiotics have zero therapeutic effect on the common cold. Because antibiotics are strictly engineered to eliminate bacterial pathogens, they are entirely useless against viral infections like colds and influenza. While public misconceptions regarding the efficacy of "-mycin" drugs for minor viruses have declined in recent years, inappropriate usage remains high. According to data compiled by the KDCA, approximately 30% of all antibiotic prescriptions generated at hospitals and clinics across South Korea are clinically deemed inappropriate.
Curbing the spread of drug-resistant superbugs requires strict vigilance from both medical practitioners and patients. The primary drivers of accelerating resistance are two-fold: excessive or defensive over-prescribing by physicians, and the dangerous patient habit of prematurely discontinuing an antibiotic course once symptoms begin to improve. For these critical therapies to work when they are truly needed to save a life, both sides must commit to strict medicinal stewardship.
